Starting a discussion about Novoeight®

Whether new to hemophilia treatment or considering a switch to Novoeight®, patients and caregivers will most likely have questions about treatment: Will Novoeight® control my bleeds? Will Novoeight® fit my lifestyle? How will I pay for treatment?

We have designed this counseling tool to help you address the concerns patients and caregivers may have. Included in it is:

  • Information about how Novoeight® fits into his world, including its portability, reliability, and purity
  • A series of statements your patients can answer to help you best understand what is important to them in a treatment
  • Descriptions of resources that can help them get started on treatment
  • Information on how to dose and prescribe Novoeight®
  • A tear pad where you can note your patient's dose and regimen to help him remember your in-office discussions

Ask a local Novo Nordisk Representative for a copy of this useful tool and about other resources that can help you talk with patients.

Novoeight Counsel The Switch


 



 

Novoeight® Start Guide

Getting him started

Connect to the resources that can help him have a successful start with Novoeight®.

Novoeight Demo Kit

Novoeight® Demo Kit

Ask a Novo Nordisk Representative for a Novoeight® Demonstration Kit, which lets your patient practice reconstituting a dose before he starts treatment, so he can see how quick it is.

Patients should not attempt to self-infuse unless they have first been instructed by their healthcare provider or hemophilia treatment center. Contact a local Rep to learn more.


 



 

Selected Important Safety Information

Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins.

Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is indicated for use in adults and children with hemophilia A for control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Novoeight® is not indicated for the treatment of von Willebrand disease.
 

Important Safety Information

Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins.

Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment.

Development of activity-neutralizing antibodies (inhibitors) may occur.  If expected plasma factor VIII activity levels are not attained, or if bleeding is not controlled with an appropriate dose, perform an assay that measures factor VIII inhibitor concentration.

The most frequently reported adverse reactions (≥0.5%) were injection site reactions, increased hepatic enzymes, and pyrexia.


Please click here for Novoeight® Prescribing Information.